1. Melanoma and vitiligo: immunology’s Grecian urn

   • D. Berd
   • Michael J. Mastrangelo
   • Henry C. Maguire Jr.

   REVIEW Pages: 263 - 267

2. Protective effect of an acidic glycoprotein obtained from culture of Chlorella vulgaris against myelosuppression by 5-fluorouracil

   • F. Konishi
   • Masao Mitsuyama
   • Kikuo Nomoto

   ORIGINAL ARTICLE Pages: 268 - 274

3. Induction of gene expression for nitric oxide synthase by immunomodulating drugs in the RAW264.7 murine macrophage cell line

   • Kiyoshi Asai
   • Haruki Kato
   • K. Hirose

   ORIGINAL ARTICLE Pages: 275 - 279

4. Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-γ, which inhibits B16F10 melanoma cell growth in vitro

   • Toshihiro Fujimoto
   • Michael A. O’Donnell
   • R. B. Duda

   ORIGINAL ARTICLE Pages: 280 - 284

5. Suppressive effects of Lactobacillus casei cells, a bacterial immunostimulant, on the incidence of spontaneous thymic lymphoma in AKR mice

   • Takashi Watanabe

   ORIGINAL ARTICLE Pages: 285 - 290

6. ^99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin’s lymphoma

   • Susan F. Vervoordeldonk
   • Janneke Heikens
   • Rien H. J. van Oers

   ORIGINAL ARTICLE Pages: 291 - 296

7. Anti-tyrosinase antibodies in malignant melanoma

   • Ofer Merimsky
   • Ehud Baharav
   • Pnina Fishman

   ORIGINAL ARTICLE Pages: 297 - 302

8. Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69⁺ lymphocytes correlate with effects of Theratope® sialyl-Tn-KLH cancer vaccine in active specific immunotherapy

   • Mark A. Reddish
   • Grant D. MacLean
   • B. M. Longenecker

   ORIGINAL ARTICLE Pages: 303 - 309

9. Effect of intraperitoneal administration of granulocyte/macrophage-colony-stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro

   • H. J. P. M. Koenen
   • Marjon J. Smit
   • Sybren Meijer

   ORIGINAL ARTICLE Pages: 310 - 316